Topics
Glioblastoma | Diagnosis | Magnetic resonance imaging
Home > Publications > Topics > Glioblastoma > Diagnosis > Magnetic resonance imaging
Joseph C.
Guess What Is in My Brain.
J
Adv Pract Oncol. 2024 Jan 1;15(1):60-64. doi:
10.6004/jadpro.2024.15.1.7. PMID:
39119082. Case report. ˍ
Kikuchi K, Togao O, Yamashita K, Momosaka D, Kikuchi Y, Kuga D,
Yuhei S, Fujioka Y, Narutomi F, Obara M, Yoshimoto K, Ishigami
K.
Comparison of diagnostic performance
of radiologist- and AI-based assessments of T2-FLAIR mismatch sign
and quantitative assessment using synthetic MRI in the
differential diagnosis between astrocytoma, IDH-mutant and
oligodendroglioma, IDH-mutant and
1p/19q-codeleted.
Neuroradiology.
2024 Jan 15. doi:
10.1007/s00234-024-03288-0. PMID:
38224343. Observational study. ˍ
Mirzayeva L, Uçar M, Kaymaz AM, Temel E.
Intraoperative
magnetic resonance imaging in glioma surgery: a single-center
experience.
J
Neurooncol. 2024 Apr 3. doi:
10.1007/s11060-024-04660-z. PMID:
38568377. Observational study. ˍ
Ghimire P, Kinnersley B, Karami G, Arumugam P, Houlston R, Ashkan
K, Modat M, Booth TC.
Radiogenomic
biomarkers for immunotherapy in glioblastoma: A systematic review
of magnetic resonance imaging studies.
Neurooncol
Adv. 2024 Apr 5;6(1):vdae055. doi:
10.1093/noajnl/vdae055. PMID:
38680991. Review. ˍ
Low JCM, Cao J, Hesse F, Wright AJ, Tsyben A, Alshamleh I, Mair R,
Brindle KM.
Deuterium metabolic imaging
differentiates glioblastoma metabolic subtypes and detects early
response to chemoradiotherapy.
Cancer
Res. 2024 Apr 18. doi:
10.1158/0008-5472.CAN-23-2552. PMID:
38635885. Laboratory investigation.
ˍ
Zhao
X, Ren X, Li M, Jiang H, Li M, Wan H, Zhang Y, Lin S, Zhou D.
Subventricular
zone-associated classification in isocitrate
dehydrogenase-wildtype glioblastomas: improved prognostic value
through integration of FLAIR with contrast-enhanced imaging.
J
Neurosurg.
2024 Jun 28:1-10. doi:
10.3171/2024.4.JNS232658. PMID:
38941641. Observational study˰ ˍ
Syed W, Ibatullin M.
Glioblastoma:
Overview and Magnetic Resonance Spectroscopy Analysis for
Treatment.
Cureus.
2024 Aug 7;16(8):e66390. doi:
10.7759/cureus.66390. PMID:
39247004. Review. ˍ
Lu W, Feng J, Zou Y, Liu Y, Gao P, Zhao Y, Wu X, Ma H.
1H-MRS
parameters in non-enhancing peritumoral regions can predict the
recurrence of glioblastoma.
Sci
Rep. 2024 Nov 26;14(1):29258. doi:
10.1038/s41598-024-80610-z. PMID:
39587278. Observational study. ˍ